{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:10:59Z","timestamp":1761919859487},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T00:00:00Z","timestamp":1404864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0101656","type":"journal-article","created":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T19:34:07Z","timestamp":1404934447000},"page":"e101656","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["MicroRNAs Discriminate Familial from Sporadic Non-BRCA1\/2 Breast Carcinoma Arising in Patients \u226435 Years"],"prefix":"10.1371","volume":"9","author":[{"given":"Elen Pereira","family":"Bastos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Brentani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima Solange","family":"Pasini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aderbal Ruy T.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar Henrique","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato David","family":"Puga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloisa Helena Ribeiro","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Rusiska","family":"Piovezani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Alberto de Bragan\u00e7a","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Machado-Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirce Maria","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Mitzi","family":"Brentani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,7,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/jnci\/djn344","article-title":"Recent trends in breast cancer among younger women in the United States","volume":"100","author":"LA Brinton","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"ref2","volume":"20","unstructured":"El Saghir NS, Seoud M, Khalil MK, Charafeddine M, Salem ZK, <etal>et al<\/etal>.. (2006) Effects of young age at presentation on survival in breast cancer. BMC Cancer <volume>20<\/volume>: : 6\u2013194. PubMed: 16857060."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.breast.2011.07.012","article-title":"Patients 35 years old or younger with operable breast cancer are more at risk for relapse and survival: a retrospective matched case-control study","volume":"20","author":"R Peng","year":"2011","journal-title":"Breast"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10549-009-0388-z","article-title":"Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer","volume":"119","author":"W Han","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/COC.0b013e3181d6b500","article-title":"Association between very young age and adverse characteristics of breast cancer at presentation amongst Israeli women","volume":"34","author":"S Paluch-Shimon","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s12253-013-9635-z","article-title":"Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of hungarian patients","volume":"19","author":"L Madaras","year":"2013","journal-title":"Pathol Oncol Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e7695","DOI":"10.1371\/journal.pone.0007695","article-title":"Breast cancer in young women: poor survival despite intensive treatment","volume":"4","author":"H Fredholm","year":"2009","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.breast.2013.08.006","article-title":"Pathological features and survival outcomes of very young patients with early breast cancer: How much is &quot;very young&quot;?","volume":"22","author":"G Cancello","year":"2013","journal-title":"Breast"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","article-title":"Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression","volume":"26","author":"CK Anders","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/AOG.0b013e318291ef9a","article-title":"Breast cancer in women aged 25 years and younger","volume":"121","author":"C Dimitrakakis","year":"2013","journal-title":"Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/jclinpath-2011-200064","article-title":"Prognostic molecular markers in women aged 35 years or younger with breast cancer: is there a difference from the older patients?","volume":"64","author":"CH Lin","year":"2011","journal-title":"J Clin Pathol"},{"key":"ref12","volume":"11","unstructured":"Tichy JR, Lim E, Anders CK (2013) Breast cancer in adolescents and young adults: a review with a focus on biology. J Natl Compr Canc Netw <volume>11<\/volume>: : 1060\u20131069. PubMed: 24029122."},{"key":"ref13","volume":"7","unstructured":"Fackenthal JD, Olopade OI (2007) Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer <volume>7<\/volume>: : 937\u2013948. Review. PubMed: 18034184."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/annonc\/mdp051","article-title":"Breast cancer in young women (YBC): prevalence of BRCA1\/2 mutations and risk of secondary malignancies across diverse racial groups","volume":"20","author":"BG Haffty","year":"2009","journal-title":"Ann Oncol"},{"key":"ref15","volume":"106","unstructured":"de Sanjos\u00e9 S, L\u00e9on\u00e9 M, B\u00e9rez V, Izquierdo A, Font R, <etal>et al<\/etal>.. (2003) Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study. Int J Cancer <volume>106<\/volume>: : 588\u2013593. PubMed: 12845657."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1200\/JCO.2010.28.9199","article-title":"Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes?","volume":"29","author":"CK Anders","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref17","volume":"15","unstructured":"Keegan TH, Press DJ, Tao L, Derouen MC, Kurian AW, <etal>et al<\/etal>.. (2013) Impact of breast cancer subtypes on three-year survival among adolescent and young adult women. Breast Cancer Res <volume>15<\/volume>: : R95. PubMed: 24131591."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1158\/1078-0432.CCR-11-2599","article-title":"Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling","volume":"18","author":"HA Azim Jr","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e57581","DOI":"10.1371\/journal.pone.0057581","article-title":"Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil","volume":"8","author":"DM Carraro","year":"2013","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.seminoncol.2011.08.005","article-title":"MicroRNAs: toward the clinic for breast cancer patients","volume":"38","author":"M Ferracin","year":"2011","journal-title":"Semin Oncol"},{"key":"ref21","volume":"29","unstructured":"Shi M, Liu D, Duan H, Shen B, Guo N (2010) Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis. Cancer Metastasis Rev <volume>29<\/volume>: : 785\u201399. PubMed: 10.1007\/s10555-010-9265-9."},{"key":"ref22","volume":"8","unstructured":"Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, <etal>et al<\/etal>.. (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol <volume>8<\/volume>: : R214. PubMed: 17922911."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.1304977110","article-title":"Prognostic microRNA\/mRNA signature from the integrated analysis of patients with invasive breast cancer","volume":"110","author":"S Volinia","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1158\/0008-5472.CAN-11-0489","article-title":"microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer","volume":"71","author":"FM Buffa","year":"2011","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/carcin\/bgn172","article-title":"A functional polymorphism in the miR-146a gene and age of familial breast\/ovarian cancer diagnosis","volume":"29","author":"J Shen","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/carcin\/bgq184","article-title":"Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1\/BRCA2-negative familial breast and ovarian cancer patients","volume":"31","author":"C Pastrello","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1038\/bjc.2013.612","article-title":"MicroRNA-based molecular classification of non-BRCA1\/2 hereditary breast tumours","volume":"109","author":"M Tanic","year":"2013","journal-title":"Br J Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10549-013-2723-7","article-title":"MicroRNA signatures in hereditary breast cancer","volume":"142","author":"R Murria Estal","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"ref29","volume":"13","unstructured":"Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, <etal>et al<\/etal>.. (2007) The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res <volume>13<\/volume>: : 2329\u20132334. PubMed: 17438091."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s00432-012-1288-x","article-title":"A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7","volume":"138","author":"C Wang","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref31","volume":"21","unstructured":"Smyth GK, Michaud J, Scott HS (2005) Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics <volume>21<\/volume>: : 2067\u20132075. PubMed: 15657102."},{"key":"ref32","unstructured":"Chu GB, Narasimhan R, Tibshirani R, Tusher V (2001) SAM Significance Analysis of Microarrays users guide and technical document. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/statweb.stanford.edu\/~tibs\/SAM\/\" xlink:type=\"simple\">http:\/\/statweb.stanford.edu\/~tibs\/SAM\/<\/ext-link>"},{"key":"ref33","volume":"34","unstructured":"Saeed AI, Sharov V, White J, Li J, Liang W, <etal>et al<\/etal>.. (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques <volume>34<\/volume>: : 374\u2013378. PubMed: 12613259."},{"key":"ref34","volume":"44","unstructured":"Browne MW (2000) Cross-Validation Methods. J Math Psychol <volume>44<\/volume>: : 108-132. PubMed: 10733860."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e48751","DOI":"10.1371\/journal.pone.0048751","article-title":"Transcriptional alterations related to neuropathology and clinical manifestation of Alzheimer&apos;s disease","volume":"7","author":"AR Silva","year":"2012","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1158\/0008-5472.CAN-11-0608","article-title":"MicroRNA sequence and expression analysis in breast tumors by deep sequencing","volume":"71","author":"TA Farazi","year":"2011","journal-title":"Cancer Res"},{"key":"ref37","volume":"3","unstructured":"Siragam V, Rutnam ZJ, Yang W, Fang L, Luo L, <etal>et al<\/etal>.. (2012) MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11. Oncotarget <volume>3<\/volume>: : 1370\u20131385. PubMed: 23211491."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/carcin\/bgs383","article-title":"MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer","volume":"34","author":"YJ Liang","year":"2013","journal-title":"Carcinogenesis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"821","DOI":"10.5732\/cjc.011.10289","article-title":"miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro","volume":"30","author":"XB Lv","year":"2011","journal-title":"Chin J Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/1471-2164-14-265","article-title":"Simultaneous miRNA and mRNA transcriptome profiling of human myoblasts reveals a novel set of myogenic differentiation-associated miRNAs and their target genes","volume":"14","author":"P Dmitriev","year":"2013","journal-title":"BMC Genomics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/jor.22457","article-title":"Analysis of microRNAs expressions in chondrosarcoma","volume":"31","author":"T Yoshitaka","year":"2013","journal-title":"J Orthop Res"},{"key":"ref42","first-page":"e1002751","article-title":"MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells. PLoS Genet","volume":"8","author":"S Liu","year":"2012"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/1471-2407-8-302","article-title":"STAT3 can be activated through paracrine signaling in breast epithelial cells","volume":"8","author":"JC Lieblein","year":"2008","journal-title":"BMC Cancer"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/1477-3163.90677","article-title":"The two faces of Janus kinases and their respective STATs in mammary gland development and cancer","volume":"10","author":"KU Wagner","year":"2011","journal-title":"J Carcinog"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"de Graauw M, Cao L, Winkel L, van Miltenburg MH, le D\u00e9v\u00e9dec SE, <etal>et al<\/etal>.. (2013) Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation. Oncogene: In press. doi: 10.1038\/onc.2013.219. PubMed: 23792445","DOI":"10.1038\/onc.2013.219"},{"key":"ref46","volume":"282","unstructured":"Tompkins VS, Hagen J, Frazier AA, Lushnikova T, Fitzgerald MP, <etal>et al<\/etal>.. (2007) A novel nuclear interactor of ARF and MDM2 (NIAM) that maintains chromosomal stability. J Biol Chem <volume>282<\/volume>: : 1322\u20131333. PubMed: 17110379."},{"key":"ref47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.humpath.2010.03.015","article-title":"Frameshift mutations of vacuolar protein sorting genes in gastric and colorectal cancers with microsatellite instability","volume":"43","author":"CH An","year":"2012","journal-title":"Hum Pathol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1111\/j.1349-7006.2012.02407.x","article-title":"Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma","volume":"103","author":"K Kashimoto","year":"2012","journal-title":"Cancer Sci"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1021\/ja312210c","article-title":"Investigation of SSEA-4 binding protein in breast cancer cells","volume":"135","author":"TC Hung","year":"2013","journal-title":"J Am Chem Soc"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1210\/en.2012-1558","article-title":"17\u03b2-estradiol activates glucose uptake via GLUT4 translocation and PI3K\/Akt signaling pathway in MCF-7 cells","volume":"154","author":"P Garrido","year":"2013","journal-title":"Endocrinology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/cdd.2012.62","article-title":"SIRT3 protects from hypoxia and staurosporine-mediated cell death by maintaining mitochondrial membrane potential and intracellular pH","volume":"19","author":"L Pellegrini","year":"2012","journal-title":"Cell Death Differ"},{"key":"ref52","volume":"318","unstructured":"Vasudevan S, Tong Y, Steitz JA (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science <volume>318<\/volume>: : 1931\u20131934. PubMed: 18048652."},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e8898","DOI":"10.1371\/journal.pone.0008898","article-title":"Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer&apos;s disease cortex reveals altered miRNA regulation","volume":"5","author":"J Nunez-Iglesias","year":"2010","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"R24","DOI":"10.1186\/bcr2839","article-title":"Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer","volume":"13","author":"BN Hannafon","year":"2011","journal-title":"Breast Cancer Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/ijc.25603","article-title":"Transcription characteristics of familial non-BRCA1\/BRCA2 breast tumors","volume":"128","author":"R Fernandez-Ramires","year":"2011","journal-title":"Int J Cancer"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0101656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T19:33:40Z","timestamp":1540323220000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0101656"}},"subtitle":[],"editor":[{"given":"Sonia","family":"Rocha","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,9]]},"references-count":55,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0101656","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,9]]}}}